Reading DD? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track DD free→Reading DD? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track DD free→NYSEMaterialsSpecialty ChemicalsSnapshot 2026-06-16
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
Recent financial performance is neutral, and earnings quality is fragile, reported profits aren't backed by cash. Management's recent track record has been unsteady, with frequent disruptive corporate changes, while the sector backdrop is a headwind. Peer multiples imply a price about 4% below where it trades (it looks expensive on this basis); the read is fair, but weakening. If DD cuts guidance on the next call, that's a meaningful negative. This read is provisional.
Daily closes. Earnings/event dots are placed inline.
A consensus fair price across 7 valuation methods, at three horizons. Current price $48.05. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
No-growth: today's peer multiple on trailing earnings. The headline read.
Embeds projected growth. Leans optimistic by design. Upside context.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $49 DD trades at 15× p/e, below its 21× p/e peer median. Our $47 fair value sits above the price; medium confidence. Analysts: $53–$60. Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
The market is pricing in roughly 4% near-term growth, in line with our forecast of about 6%. This describes what's priced in, not a forecast of the move.
Only weak execution quality — not the full expensive x weak x turbulent stack. Regime (Crisis) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Each factor is a parallel diagnostic with a clear read of what it shows and how names like it have historically fared. Never aggregated into a single score.
Operating income rose in 2 of the last 3 quarter-over-quarter moves. Historically, Materials names rated neutral grew net income 56% of the time over the next year (vs 57% for the rest of the cohort, n=1462).
Over the trailing year it converted 0.85x of net income into operating cash flow. Historically, Materials names rated fragile grew net income 46% of the time over the next year (vs 57% for the rest of the cohort, n=988).
Most sensitive to the broad stock market.
Not enough signal to read sensitivity to the US dollar, real (inflation-adjusted) rates, Fed net liquidity, long-term interest rates.
The next print and the backdrop around it (sector regime and the AI cycle). Context for the path, not a forecast of returns.
EPS estimate $0.59 → $0.59 (-0.5% / 30d). 5 raised, 6 cut, 13 covering analysts.
0 upgrades, 0 downgrades / 30d. 81% of analysts rate Buy.
1 PT revisions / 30d. Avg target 9.8% above current price.
How management runs the business: capital, margins, balance sheet, and how reliably they guide and deliver.
What a normal day, a bad day, and the worst of the last year would mean for a $10,000 position.
On a typical day, $10k can swing ±$143.
How much price usually moves either way.
On a bad day, this stock has moved -$278.
A rough but not unusual down day (about the 95th percentile).
In the worst 12 months, $10k could have lost $1,731.
Deepest peak-to-trough drop in the last year.
Past results, not a forecast. Not investment advice.
The most important moves since the prior daily snapshot.
No material changes since the prior snapshot.
as of 2026-06-16
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
Why it matters: Meeting this growth target shows DuPont is on track for its 4% annual goal. It reflects strong demand and effective execution.
Confirms:Q2 2026 organic sales growth reported at or above 3%.
Disproves:Q2 2026 organic sales growth was below 3%.
Recent news graded against this company's own objectives — whether it reinforces or challenges the thesis, and how confirmed it is.
No graded news catalysts for DD yet.
Conditional scenarios: if X happens, the view would shift in this direction. These are not predictions.
No upside scenarios in the latest snapshot.
No downside scenarios in the latest snapshot.
Recent SEC 8-K filings ranked by likely impact, confidence, and recency.
Results of Operations and Financial Condition. On May 5, 2026, DuPont de Nemours, Inc. (the "Company") issued a press release, attached as Exhibit 99.1, and incorporated herein by reference, announcing results for the first quarter 2026. The information contained in this report, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, (the "Exchange Act") or otherwise subject to the…
Whether the overall read has been drifting up or down lately, and how it's changed since last week.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Long-thesis check; widest uncertainty.
$53.00 – $60.00 (median $58.00) · 5 analysts · as of 2026-06-15
Looks cheaper than most peers in the same business.
Cheaper than its own typical valuation.
Trailing four: 2025-Q1, 2025-Q2, 2025-Q3, 2026-Q1
A side-by-side read on sector standing, valuation, and risk versus Specialty Chemicals.
| Stock | Sector standing | Valuation | Risk |
|---|---|---|---|
DD DuPont | Above typical Show detailsSector percentile: 93 of 100 | full | moderate |
SHW Sherwin-Williams | Typical Show detailsSector percentile: 66 of 100 | full | moderate |
ECL Ecolab | Above typical Show detailsSector percentile: 83 of 100 | expensive | moderate |
PPG PPG Industries | Above typical Show detailsSector percentile: 90 of 100 | fair | moderate |
LYB LyondellBasell | Typical Show detailsSector percentile: 55 of 100 | — | moderate |
18 material management or governance events in the past 24 months, led by capital-allocation actions. Historically, Materials names rated volatile grew net income 61% of the time over the next year (vs 51% for the rest of the cohort, n=235).
Not investment advice. As of 2026-06-16.
via XLB
Tailwind = sector leading the S&P 500; headwind = trailing. Both can be constructive. Historically, headwind regimes have averaged stronger forward returns than tailwind.
Context label only: describes the market state (e.g. real bear vs narrative panic, healthy uptrend vs late-stage froth). It is not a per-ticker buy/sell signal and does not predict factor performance.
Not investment advice. As of 2026-06-16.
Met or beat guidance 88% of the last 8 guided quarters · 32.1% avg surprise
Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.
DuPont aims for 4% organic growth in 2026, including 1% from pricing actions.
DuPont has raised its full year 2026 EPS guidance to $2.35 - $2.40.
DuPont plans to launch a $275 million accelerated share repurchase imminently.
Ensure that the 2026 financial guidance aligns with the company's medium-term targets.
Oversee the transition of the CEO to ensure leadership continuity.
Why it matters: Raising EPS guidance shows better earnings and more growth confidence.
Confirms:Management raises full year 2026 EPS guidance during the Q3 earnings call.
Disproves:Management maintains or lowers EPS guidance during the Q3 earnings call.
Why it matters: Earnings results will show if DuPont can maintain momentum after the recent earnings beat.
Confirms one read:Q2 earnings beat expectations similar to Q1.
Confirms the other:Q2 earnings fall short of expectations.
Why it matters: Aligning guidance shows DuPont's commitment to long-term growth. It is crucial for investor trust.
Confirms:2026 guidance matches the medium-term goals set by management.
Disproves:2026 guidance does not match the medium-term targets.
Why it matters: The CEO change affects the company's strategy and stability. Clear updates can help investors.
Confirms one read:Management gives a good update on the CEO change process.
Confirms the other:Further delays or issues arise in the CEO transition.
Why it matters: How well the tender offer goes affects DuPont's debt and money management.
Confirms one read:The tender offer works if they accept the maximum amount.
Confirms the other:Not finishing the tender offer or taking much less than the maximum is a bad sign.
Why it matters: Qnity's results will show how well DuPont's split and focus worked.
Confirms one read:Qnity has strong earnings or growth in the first quarter after the split.
Confirms the other:Qnity has weak earnings or growth in the first quarter after the split.
Why it matters: Finishing the share buyback shows trust in cash flow and how money is used.
Confirms:A notice that the $275 million share buyback is done.
Disproves:No announcement of completion by the end of Q3 2026.
Why it matters: The success of these offers will change DuPont's debt and financial options.
Confirms:DuPont will exchange the targeted amount of 2028, 2038, and 2048 Notes by September 30, 2025.
Disproves:DuPont fails to meet the minimum tender conditions for the Exchange Offers.
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On April 13, 2026, Luke Kissam tendered his resignation as a member of the Board of Directors of DuPont de Nemours, Inc. (the “Company”), effective April 14, 2026, in connection with his future appointment as Chief Executive Officer of Corteva, Inc. Mr. Kissam’s departure is not the result of any disagreement with the Company on any matter relating…
Results of Operations and Financial Condition. On February 10, 2026, DuPont de Nemours, Inc. (the "Company") issued a press release, attached as Exhibit 99.1, and incorporated herein by reference, announcing results for the fourth quarter and full year 2025. The information contained in this report, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, (the "Exchange Act") or othe…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers On January 20, 2026 DuPont de Nemours, Inc. (the “Company”) appointed D.G. Macpherson to its Board of Directors, effective immediately. The Board of Directors determined that Mr. Macpherson is an “independent director” in accordance with the New York Stock Exchange listing standards, the rules and regulations of the Securities and Exchange Commissio…
Other Events. In connection with its Current Report on Form 8-K filed on November 3, 2025, DuPont de Nemours, Inc., a Delaware corporation (“DuPont”), indicated it would disclose the numeric percentage of the Applicable Percentage (as defined below) of DuPont and the resulting Minimum EBITDA (as defined in that certain Letter Agreement, dated as of June 1, 2019, by and between DuPont (f/k/a DowDuPont Inc.) and Corteva, Inc.) in respect of DuPont once determined after the spin-off on November…